Using MC1R Genotype to Impact Melanoma Risk Behavior

NACompletedINTERVENTIONAL
Enrollment

2,054

Participants

Timeline

Start Date

August 3, 2015

Primary Completion Date

February 19, 2021

Study Completion Date

February 19, 2021

Conditions
Melanoma (Skin)Squamous Cell CarcinomaSquamous Cell CancerSkin CancerBasal Cell CarcinomaBasal Cell Cancer
Interventions
BEHAVIORAL

Personalized Information

Personalized information about ways that participants can protect themselves and their child from developing melanoma.

BEHAVIORAL

Standard Information

Standard information about ways that participants can protect themselves and their child from developing melanoma.

OTHER

DNA Extraction Determination of MC1R Genotypes

After signing informed consent, a biologic sample (saliva) will be collected for the purpose of DNA extraction determination of MC1R genotypes. All participants who carry high risk MC1R genotypes and a proportion of those who carry low risk or no MC1R variants will be randomized to the control or intervention arm.

Trial Locations (2)

33612

H. Lee Moffitt Cancer Center and Research Institute, Tampa

00716

Ponce School of Medicine, Ponce

All Listed Sponsors
collaborator

Ponce Health Sciences University

OTHER

collaborator

University of South Florida

OTHER

collaborator

American Cancer Society, Inc.

OTHER

lead

H. Lee Moffitt Cancer Center and Research Institute

OTHER

NCT03509467 - Using MC1R Genotype to Impact Melanoma Risk Behavior | Biotech Hunter | Biotech Hunter